Brief: Bergenbio COVID-19 Data Presented At Annual American Society For Virology

Oncoinvent ASA

21/07/2021 06:04

July 21 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO COVID-19 DATA PRESENTED AT ANNUAL AMERICAN
SOCIETY FOR
VIROLOGY
    * NEW DATA INVESTIGATING BEMCENTINIB AGAINST SARS-COV-2
MUTATIONS
WAS ALSO PRESENTED
    * DATA SHOW THAT BEMCENTINIB IS ALSO EFFICACIOUS IN
PREVENTING
SARS-COV-2 INFECTION BY CARRYING CIRCULATING MUTATIONS
    * INVESTIGATORS CONCLUDED THAT PHOSPHATIDYLSERINE RECEPTORS,
SUCH
AS AXL, ENHANCE SARS-COV-2 INFECTION AND THAT INHIBITION OF AXL
IS A POTENTIALLY PROMISING THERAPEUTIC TARGET FOR COVID-19.

Source text for Eikon:  ID:nWkr2NzHxt 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))